Get started
PROCEPT BIOROBOTICS CORPPROCEPT BIOROBOTICS CORPPROCEPT BIOROBOTICS CORP

PROCEPT BIOROBOTICS CORP

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals

PRCT chart


Full chart

PRCT upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪60.00 B‬ MXN
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−36.67 MXN
Net income (FY)
‪−1.91 B‬ MXN
Revenue (FY)
‪4.68 B‬ MXN
Shares float
‪51.88 M‬
Beta (1Y)
1.12

Employees


Employees (FY)
756
Change (1Y)
+130 +20.77%
Revenue / Employee (1Y)
‪6.19 M‬ MXN
Net income / Employee (1Y)
‪−2.52 M‬ MXN

About PROCEPT BioRobotics Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
Reza Zadno
Website
procept-biorobotics.com
Headquarters
San Jose
Founded
2007
FIGI
BBG01P2VSQ22
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PRCT news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as PRCT.

Frequently Asked Questions


The current price of PRCT is 1,162.88 MXN — it has increased by 2.07% in the past 24 hours. Watch PROCEPT BIOROBOTICS CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange PROCEPT BIOROBOTICS CORP stocks are traded under the ticker PRCT.
PRCT stock hasn't changed in a week, the month change is a 2.07% rise, over the last year PROCEPT BIOROBOTICS CORP has showed a 0.27% increase.
We've gathered analysts' opinions on PROCEPT BIOROBOTICS CORP future price: according to them, PRCT price has a max estimate of 2,148.78 MXN and a min estimate of 1,432.52 MXN. Watch PRCT chart and read a more detailed PROCEPT BIOROBOTICS CORP stock forecast: see what analysts think of PROCEPT BIOROBOTICS CORP and suggest that you do with its stocks.
PRCT reached its all-time high on Oct 29, 2024 with the price of 1,820.06 MXN, and its all-time low was 1,139.30 MXN and was reached on Mar 13, 2025. View more price dynamics on PRCT chart.
See other stocks reaching their highest and lowest prices.
PRCT stock is 2.03% volatile and has beta coefficient of 1.12. Track PROCEPT BIOROBOTICS CORP stock price on the chart and check out the list of the most volatile stocks — is PROCEPT BIOROBOTICS CORP there?
Today PROCEPT BIOROBOTICS CORP has the market capitalization of ‪60.00 B‬, it has increased by 0.10% over the last week.
Yes, you can track PROCEPT BIOROBOTICS CORP financials in yearly and quarterly reports right on TradingView.
PROCEPT BIOROBOTICS CORP is going to release the next earnings report on Jul 31, 2025. Keep track of upcoming events with our Earnings Calendar.
PRCT earnings for the last quarter are −9.22 MXN per share, whereas the estimation was −10.05 MXN resulting in a 8.24% surprise. The estimated earnings for the next quarter are −7.83 MXN per share. See more details about PROCEPT BIOROBOTICS CORP earnings.
PROCEPT BIOROBOTICS CORP revenue for the last quarter amounts to ‪1.42 B‬ MXN, despite the estimated figure of ‪1.34 B‬ MXN. In the next quarter, revenue is expected to reach ‪1.50 B‬ MXN.
PRCT net income for the last quarter is ‪−393.14 M‬ MXN, while the quarter before that showed ‪−413.26 M‬ MXN of net income which accounts for 4.87% change. Track more PROCEPT BIOROBOTICS CORP financial stats to get the full picture.
No, PRCT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 24, 2025, the company has 756 employees. See our rating of the largest employees — is PROCEPT BIOROBOTICS CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PROCEPT BIOROBOTICS CORP EBITDA is ‪−1.91 B‬ MXN, and current EBITDA margin is −40.70%. See more stats in PROCEPT BIOROBOTICS CORP financial statements.
Like other stocks, PRCT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROCEPT BIOROBOTICS CORP stock right from TradingView charts — choose your broker and connect to your account.